Gene-based and molecular therapies are revolutionizing the treatment landscape for movement disorders. This track will explore gene therapy, molecular techniques such as CRISPR, and other cutting-edge approaches that hold promise for halting or reversing disease progression.
Track 22-1: Gene Therapy for Parkinson’s Disease
Track 22-2: Viral Vectors and Molecular Therapeutics
Track 22-3: Antisense Oligonucleotides in Huntington’s Disease
Track 22-4: CRISPR and Gene Editing Technologies
Track 22-5: Clinical Trials of Molecular Therapies
This track will delve into the forefront of molecular medicine and its potential to transform the treatment of neurodegenerative diseases.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
